Skip to main content

ATTR clinical trials at UCLA

1 research study open to eligible people

Showing trials for
  • Patients With Transthyretin (ATTR) Amyloidosis

    open to eligible people ages 18-130

    The MaesTTRo study aims to enroll a global cohort of patients with transthyretin (ATTR) amyloidosis to longitudinally observe the natural course of the disease and describe real-world treatment patterns and outcomes. In addition, information on the…

    Los Angeles, California and other locations

Last updated: